世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

DNAおよびRNA汚染除去ソリューション-世界市場シェアとランキング、全体売上高と需要予測 2025-2031

DNAおよびRNA汚染除去ソリューション-世界市場シェアとランキング、全体売上高と需要予測 2025-2031


DNA and RNA Decontamination Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

DNAおよびRNA汚染除去ソリューションの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整されると予測され、予測期間2025-2031年の年平均成長率は%である。 DNAおよびRN... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年3月21日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

DNAおよびRNA汚染除去ソリューションの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整されると予測され、予測期間2025-2031年の年平均成長率は%である。

DNAおよびRNA汚染除去液は、あらゆる表面、特にPCRワークステーション、ラボ機器、ピペッティング機器などからDNAを除去するための液体である。
DNAおよびRNA汚染除去液の北米市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に年平均成長率%で、2031年までに100万ドルに達する見込みです。
DNAおよびRNA汚染除去ソリューションのアジア太平洋市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に年平均成長率%で、2031年までに100万ドルに達する見込みです。
DNAおよびRNA汚染除去ソリューションのヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に年平均成長率%で、2031年までに100万ドルに達する見込みです。

DNA and RNA Decontamination Solutionの世界の主要企業には、Thermo Fisher Scientific、Merck、ITW Reagents、Minerva Biolabs、Biosan、Kogene Biotech、MP Biomedicals、Takara Bio、G-Biosciences、Nacalai Tesqueなどがある。2024年には、世界の大手5社が売上高で約 %のシェアを占めている。
本レポートは、DNA/RNA汚染除去ソリューションの世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別のDNA/RNA汚染除去ソリューションの分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当てています。

DNA・RNA汚染除去ソリューションの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売量(ML)と販売収入(百万ドル)で提供されます。定量的・定性的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、DNAおよびRNA汚染除去ソリューションに関する十分な情報に基づいたビジネス上の意思決定を行うのに役立ちます。

市場区分
企業別
サーモフィッシャーサイエンティフィック
メルク
ITW試薬
ミネルババイオラボ
バイオサン
コジーン・バイオテック
MPバイオメディカルズ
タカラバイオ
ジービオサイエンス
ナカライテスク
アークティックザイムズ・テクノロジーズ
カール・ロス
デコンラボ
GenDEPOT
エンゾライフサイエンス
バザイム
江蘇カウインバイオテック
北京ジェンスター
タイプ別セグメント
濃縮核酸除去剤
すぐに使える核酸除去剤
用途別セグメント
研究所
病院
その他
地域別
北米
米国
カナダ
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア太平洋地域
欧州
ドイツ
フランス
英国
イタリア
オランダ
北欧諸国
その他のヨーロッパ
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートの対象範囲、世界の総市場規模(金額、数量、価格)を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章 DNA・RNA除染ソリューションメーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第3章:各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見つけやすくします。
第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。
第5章:地域レベルでのDNAおよびRNA汚染除去ソリューションの売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介する。
第6章 DNA・RNA除染ソリューションの国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章:主要企業のプロフィールを提供し、製品の売上高、収益、価格、粗利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:結論


ページTOPに戻る


目次

1 Market Overview
1.1 DNA and RNA Decontamination Solution Product Introduction
1.2 Global DNA and RNA Decontamination Solution Market Size Forecast
1.2.1 Global DNA and RNA Decontamination Solution Sales Value (2020-2031)
1.2.2 Global DNA and RNA Decontamination Solution Sales Volume (2020-2031)
1.2.3 Global DNA and RNA Decontamination Solution Sales Price (2020-2031)
1.3 DNA and RNA Decontamination Solution Market Trends & Drivers
1.3.1 DNA and RNA Decontamination Solution Industry Trends
1.3.2 DNA and RNA Decontamination Solution Market Drivers & Opportunity
1.3.3 DNA and RNA Decontamination Solution Market Challenges
1.3.4 DNA and RNA Decontamination Solution Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA and RNA Decontamination Solution Players Revenue Ranking (2024)
2.2 Global DNA and RNA Decontamination Solution Revenue by Company (2020-2025)
2.3 Global DNA and RNA Decontamination Solution Players Sales Volume Ranking (2024)
2.4 Global DNA and RNA Decontamination Solution Sales Volume by Company Players (2020-2025)
2.5 Global DNA and RNA Decontamination Solution Average Price by Company (2020-2025)
2.6 Key Manufacturers DNA and RNA Decontamination Solution Manufacturing Base and Headquarters
2.7 Key Manufacturers DNA and RNA Decontamination Solution Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of DNA and RNA Decontamination Solution
2.9 DNA and RNA Decontamination Solution Market Competitive Analysis
2.9.1 DNA and RNA Decontamination Solution Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by DNA and RNA Decontamination Solution Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA and RNA Decontamination Solution as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Concentrated Nucleic Acid Remover
3.1.2 Ready-to-use Nucleic Acid Remover
3.2 Global DNA and RNA Decontamination Solution Sales Value by Type
3.2.1 Global DNA and RNA Decontamination Solution Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global DNA and RNA Decontamination Solution Sales Value, by Type (2020-2031)
3.2.3 Global DNA and RNA Decontamination Solution Sales Value, by Type (%) (2020-2031)
3.3 Global DNA and RNA Decontamination Solution Sales Volume by Type
3.3.1 Global DNA and RNA Decontamination Solution Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global DNA and RNA Decontamination Solution Sales Volume, by Type (2020-2031)
3.3.3 Global DNA and RNA Decontamination Solution Sales Volume, by Type (%) (2020-2031)
3.4 Global DNA and RNA Decontamination Solution Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 Hospital
4.1.3 Others
4.2 Global DNA and RNA Decontamination Solution Sales Value by Application
4.2.1 Global DNA and RNA Decontamination Solution Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global DNA and RNA Decontamination Solution Sales Value, by Application (2020-2031)
4.2.3 Global DNA and RNA Decontamination Solution Sales Value, by Application (%) (2020-2031)
4.3 Global DNA and RNA Decontamination Solution Sales Volume by Application
4.3.1 Global DNA and RNA Decontamination Solution Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global DNA and RNA Decontamination Solution Sales Volume, by Application (2020-2031)
4.3.3 Global DNA and RNA Decontamination Solution Sales Volume, by Application (%) (2020-2031)
4.4 Global DNA and RNA Decontamination Solution Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global DNA and RNA Decontamination Solution Sales Value by Region
5.1.1 Global DNA and RNA Decontamination Solution Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global DNA and RNA Decontamination Solution Sales Value by Region (2020-2025)
5.1.3 Global DNA and RNA Decontamination Solution Sales Value by Region (2026-2031)
5.1.4 Global DNA and RNA Decontamination Solution Sales Value by Region (%), (2020-2031)
5.2 Global DNA and RNA Decontamination Solution Sales Volume by Region
5.2.1 Global DNA and RNA Decontamination Solution Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global DNA and RNA Decontamination Solution Sales Volume by Region (2020-2025)
5.2.3 Global DNA and RNA Decontamination Solution Sales Volume by Region (2026-2031)
5.2.4 Global DNA and RNA Decontamination Solution Sales Volume by Region (%), (2020-2031)
5.3 Global DNA and RNA Decontamination Solution Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.4.2 North America DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.5.2 Europe DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.6.2 Asia Pacific DNA and RNA Decontamination Solution Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.7.2 South America DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.8.2 Middle East & Africa DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA and RNA Decontamination Solution Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions DNA and RNA Decontamination Solution Sales Value
6.2.1 Key Countries/Regions DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.2.2 Key Countries/Regions DNA and RNA Decontamination Solution Sales Volume, 2020-2031
6.3 United States
6.3.1 United States DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.3.2 United States DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.3.3 United States DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.4.2 Europe DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.5.2 China DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.5.3 China DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.6.2 Japan DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.7.2 South Korea DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.8.2 Southeast Asia DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.9.2 India DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.9.3 India DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Scientific DNA and RNA Decontamination Solution Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Merck DNA and RNA Decontamination Solution Product Offerings
7.2.5 Merck Recent Development
7.3 ITW Reagents
7.3.1 ITW Reagents Company Information
7.3.2 ITW Reagents Introduction and Business Overview
7.3.3 ITW Reagents DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 ITW Reagents DNA and RNA Decontamination Solution Product Offerings
7.3.5 ITW Reagents Recent Development
7.4 Minerva Biolabs
7.4.1 Minerva Biolabs Company Information
7.4.2 Minerva Biolabs Introduction and Business Overview
7.4.3 Minerva Biolabs DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Minerva Biolabs DNA and RNA Decontamination Solution Product Offerings
7.4.5 Minerva Biolabs Recent Development
7.5 Biosan
7.5.1 Biosan Company Information
7.5.2 Biosan Introduction and Business Overview
7.5.3 Biosan DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Biosan DNA and RNA Decontamination Solution Product Offerings
7.5.5 Biosan Recent Development
7.6 Kogene Biotech
7.6.1 Kogene Biotech Company Information
7.6.2 Kogene Biotech Introduction and Business Overview
7.6.3 Kogene Biotech DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Kogene Biotech DNA and RNA Decontamination Solution Product Offerings
7.6.5 Kogene Biotech Recent Development
7.7 MP Biomedicals
7.7.1 MP Biomedicals Company Information
7.7.2 MP Biomedicals Introduction and Business Overview
7.7.3 MP Biomedicals DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 MP Biomedicals DNA and RNA Decontamination Solution Product Offerings
7.7.5 MP Biomedicals Recent Development
7.8 Takara Bio
7.8.1 Takara Bio Company Information
7.8.2 Takara Bio Introduction and Business Overview
7.8.3 Takara Bio DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Takara Bio DNA and RNA Decontamination Solution Product Offerings
7.8.5 Takara Bio Recent Development
7.9 G-Biosciences
7.9.1 G-Biosciences Company Information
7.9.2 G-Biosciences Introduction and Business Overview
7.9.3 G-Biosciences DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 G-Biosciences DNA and RNA Decontamination Solution Product Offerings
7.9.5 G-Biosciences Recent Development
7.10 Nacalai Tesque
7.10.1 Nacalai Tesque Company Information
7.10.2 Nacalai Tesque Introduction and Business Overview
7.10.3 Nacalai Tesque DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Nacalai Tesque DNA and RNA Decontamination Solution Product Offerings
7.10.5 Nacalai Tesque Recent Development
7.11 ArcticZymes Technologies
7.11.1 ArcticZymes Technologies Company Information
7.11.2 ArcticZymes Technologies Introduction and Business Overview
7.11.3 ArcticZymes Technologies DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 ArcticZymes Technologies DNA and RNA Decontamination Solution Product Offerings
7.11.5 ArcticZymes Technologies Recent Development
7.12 Carl Roth
7.12.1 Carl Roth Company Information
7.12.2 Carl Roth Introduction and Business Overview
7.12.3 Carl Roth DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Carl Roth DNA and RNA Decontamination Solution Product Offerings
7.12.5 Carl Roth Recent Development
7.13 Decon Labs
7.13.1 Decon Labs Company Information
7.13.2 Decon Labs Introduction and Business Overview
7.13.3 Decon Labs DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Decon Labs DNA and RNA Decontamination Solution Product Offerings
7.13.5 Decon Labs Recent Development
7.14 GenDEPOT
7.14.1 GenDEPOT Company Information
7.14.2 GenDEPOT Introduction and Business Overview
7.14.3 GenDEPOT DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 GenDEPOT DNA and RNA Decontamination Solution Product Offerings
7.14.5 GenDEPOT Recent Development
7.15 Enzo Life Sciences
7.15.1 Enzo Life Sciences Company Information
7.15.2 Enzo Life Sciences Introduction and Business Overview
7.15.3 Enzo Life Sciences DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Enzo Life Sciences DNA and RNA Decontamination Solution Product Offerings
7.15.5 Enzo Life Sciences Recent Development
7.16 Vazyme
7.16.1 Vazyme Company Information
7.16.2 Vazyme Introduction and Business Overview
7.16.3 Vazyme DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Vazyme DNA and RNA Decontamination Solution Product Offerings
7.16.5 Vazyme Recent Development
7.17 Jiangsu Cowin Biotech
7.17.1 Jiangsu Cowin Biotech Company Information
7.17.2 Jiangsu Cowin Biotech Introduction and Business Overview
7.17.3 Jiangsu Cowin Biotech DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Jiangsu Cowin Biotech DNA and RNA Decontamination Solution Product Offerings
7.17.5 Jiangsu Cowin Biotech Recent Development
7.18 Beijing GenStar
7.18.1 Beijing GenStar Company Information
7.18.2 Beijing GenStar Introduction and Business Overview
7.18.3 Beijing GenStar DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Beijing GenStar DNA and RNA Decontamination Solution Product Offerings
7.18.5 Beijing GenStar Recent Development
8 Industry Chain Analysis
8.1 DNA and RNA Decontamination Solution Industrial Chain
8.2 DNA and RNA Decontamination Solution Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA and RNA Decontamination Solution Sales Model
8.5.2 Sales Channel
8.5.3 DNA and RNA Decontamination Solution Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る


 

Summary

The global market for DNA and RNA Decontamination Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

DNA and RNA Decontamination Solution is a liquid for the elimination of DNA from any surface, especially PCR workstations, lab devices, pipetting equipment, etc.
North American market for DNA and RNA Decontamination Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for DNA and RNA Decontamination Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for DNA and RNA Decontamination Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of DNA and RNA Decontamination Solution include Thermo Fisher Scientific, Merck, ITW Reagents, Minerva Biolabs, Biosan, Kogene Biotech, MP Biomedicals, Takara Bio, G-Biosciences, Nacalai Tesque, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for DNA and RNA Decontamination Solution, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of DNA and RNA Decontamination Solution by region & country, by Type, and by Application.

The DNA and RNA Decontamination Solution market size, estimations, and forecasts are provided in terms of sales volume (ML) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA and RNA Decontamination Solution.

Market Segmentation
By Company
Thermo Fisher Scientific
Merck
ITW Reagents
Minerva Biolabs
Biosan
Kogene Biotech
MP Biomedicals
Takara Bio
G-Biosciences
Nacalai Tesque
ArcticZymes Technologies
Carl Roth
Decon Labs
GenDEPOT
Enzo Life Sciences
Vazyme
Jiangsu Cowin Biotech
Beijing GenStar
Segment by Type
Concentrated Nucleic Acid Remover
Ready-to-use Nucleic Acid Remover
Segment by Application
Laboratory
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA and RNA Decontamination Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of DNA and RNA Decontamination Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of DNA and RNA Decontamination Solution in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview
1.1 DNA and RNA Decontamination Solution Product Introduction
1.2 Global DNA and RNA Decontamination Solution Market Size Forecast
1.2.1 Global DNA and RNA Decontamination Solution Sales Value (2020-2031)
1.2.2 Global DNA and RNA Decontamination Solution Sales Volume (2020-2031)
1.2.3 Global DNA and RNA Decontamination Solution Sales Price (2020-2031)
1.3 DNA and RNA Decontamination Solution Market Trends & Drivers
1.3.1 DNA and RNA Decontamination Solution Industry Trends
1.3.2 DNA and RNA Decontamination Solution Market Drivers & Opportunity
1.3.3 DNA and RNA Decontamination Solution Market Challenges
1.3.4 DNA and RNA Decontamination Solution Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA and RNA Decontamination Solution Players Revenue Ranking (2024)
2.2 Global DNA and RNA Decontamination Solution Revenue by Company (2020-2025)
2.3 Global DNA and RNA Decontamination Solution Players Sales Volume Ranking (2024)
2.4 Global DNA and RNA Decontamination Solution Sales Volume by Company Players (2020-2025)
2.5 Global DNA and RNA Decontamination Solution Average Price by Company (2020-2025)
2.6 Key Manufacturers DNA and RNA Decontamination Solution Manufacturing Base and Headquarters
2.7 Key Manufacturers DNA and RNA Decontamination Solution Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of DNA and RNA Decontamination Solution
2.9 DNA and RNA Decontamination Solution Market Competitive Analysis
2.9.1 DNA and RNA Decontamination Solution Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by DNA and RNA Decontamination Solution Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA and RNA Decontamination Solution as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Concentrated Nucleic Acid Remover
3.1.2 Ready-to-use Nucleic Acid Remover
3.2 Global DNA and RNA Decontamination Solution Sales Value by Type
3.2.1 Global DNA and RNA Decontamination Solution Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global DNA and RNA Decontamination Solution Sales Value, by Type (2020-2031)
3.2.3 Global DNA and RNA Decontamination Solution Sales Value, by Type (%) (2020-2031)
3.3 Global DNA and RNA Decontamination Solution Sales Volume by Type
3.3.1 Global DNA and RNA Decontamination Solution Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global DNA and RNA Decontamination Solution Sales Volume, by Type (2020-2031)
3.3.3 Global DNA and RNA Decontamination Solution Sales Volume, by Type (%) (2020-2031)
3.4 Global DNA and RNA Decontamination Solution Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 Hospital
4.1.3 Others
4.2 Global DNA and RNA Decontamination Solution Sales Value by Application
4.2.1 Global DNA and RNA Decontamination Solution Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global DNA and RNA Decontamination Solution Sales Value, by Application (2020-2031)
4.2.3 Global DNA and RNA Decontamination Solution Sales Value, by Application (%) (2020-2031)
4.3 Global DNA and RNA Decontamination Solution Sales Volume by Application
4.3.1 Global DNA and RNA Decontamination Solution Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global DNA and RNA Decontamination Solution Sales Volume, by Application (2020-2031)
4.3.3 Global DNA and RNA Decontamination Solution Sales Volume, by Application (%) (2020-2031)
4.4 Global DNA and RNA Decontamination Solution Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global DNA and RNA Decontamination Solution Sales Value by Region
5.1.1 Global DNA and RNA Decontamination Solution Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global DNA and RNA Decontamination Solution Sales Value by Region (2020-2025)
5.1.3 Global DNA and RNA Decontamination Solution Sales Value by Region (2026-2031)
5.1.4 Global DNA and RNA Decontamination Solution Sales Value by Region (%), (2020-2031)
5.2 Global DNA and RNA Decontamination Solution Sales Volume by Region
5.2.1 Global DNA and RNA Decontamination Solution Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global DNA and RNA Decontamination Solution Sales Volume by Region (2020-2025)
5.2.3 Global DNA and RNA Decontamination Solution Sales Volume by Region (2026-2031)
5.2.4 Global DNA and RNA Decontamination Solution Sales Volume by Region (%), (2020-2031)
5.3 Global DNA and RNA Decontamination Solution Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.4.2 North America DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.5.2 Europe DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.6.2 Asia Pacific DNA and RNA Decontamination Solution Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.7.2 South America DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa DNA and RNA Decontamination Solution Sales Value, 2020-2031
5.8.2 Middle East & Africa DNA and RNA Decontamination Solution Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA and RNA Decontamination Solution Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions DNA and RNA Decontamination Solution Sales Value
6.2.1 Key Countries/Regions DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.2.2 Key Countries/Regions DNA and RNA Decontamination Solution Sales Volume, 2020-2031
6.3 United States
6.3.1 United States DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.3.2 United States DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.3.3 United States DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.4.2 Europe DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.5.2 China DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.5.3 China DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.6.2 Japan DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.7.2 South Korea DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.8.2 Southeast Asia DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India DNA and RNA Decontamination Solution Sales Value, 2020-2031
6.9.2 India DNA and RNA Decontamination Solution Sales Value by Type (%), 2024 VS 2031
6.9.3 India DNA and RNA Decontamination Solution Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Scientific DNA and RNA Decontamination Solution Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Merck DNA and RNA Decontamination Solution Product Offerings
7.2.5 Merck Recent Development
7.3 ITW Reagents
7.3.1 ITW Reagents Company Information
7.3.2 ITW Reagents Introduction and Business Overview
7.3.3 ITW Reagents DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 ITW Reagents DNA and RNA Decontamination Solution Product Offerings
7.3.5 ITW Reagents Recent Development
7.4 Minerva Biolabs
7.4.1 Minerva Biolabs Company Information
7.4.2 Minerva Biolabs Introduction and Business Overview
7.4.3 Minerva Biolabs DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Minerva Biolabs DNA and RNA Decontamination Solution Product Offerings
7.4.5 Minerva Biolabs Recent Development
7.5 Biosan
7.5.1 Biosan Company Information
7.5.2 Biosan Introduction and Business Overview
7.5.3 Biosan DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Biosan DNA and RNA Decontamination Solution Product Offerings
7.5.5 Biosan Recent Development
7.6 Kogene Biotech
7.6.1 Kogene Biotech Company Information
7.6.2 Kogene Biotech Introduction and Business Overview
7.6.3 Kogene Biotech DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Kogene Biotech DNA and RNA Decontamination Solution Product Offerings
7.6.5 Kogene Biotech Recent Development
7.7 MP Biomedicals
7.7.1 MP Biomedicals Company Information
7.7.2 MP Biomedicals Introduction and Business Overview
7.7.3 MP Biomedicals DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 MP Biomedicals DNA and RNA Decontamination Solution Product Offerings
7.7.5 MP Biomedicals Recent Development
7.8 Takara Bio
7.8.1 Takara Bio Company Information
7.8.2 Takara Bio Introduction and Business Overview
7.8.3 Takara Bio DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Takara Bio DNA and RNA Decontamination Solution Product Offerings
7.8.5 Takara Bio Recent Development
7.9 G-Biosciences
7.9.1 G-Biosciences Company Information
7.9.2 G-Biosciences Introduction and Business Overview
7.9.3 G-Biosciences DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 G-Biosciences DNA and RNA Decontamination Solution Product Offerings
7.9.5 G-Biosciences Recent Development
7.10 Nacalai Tesque
7.10.1 Nacalai Tesque Company Information
7.10.2 Nacalai Tesque Introduction and Business Overview
7.10.3 Nacalai Tesque DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Nacalai Tesque DNA and RNA Decontamination Solution Product Offerings
7.10.5 Nacalai Tesque Recent Development
7.11 ArcticZymes Technologies
7.11.1 ArcticZymes Technologies Company Information
7.11.2 ArcticZymes Technologies Introduction and Business Overview
7.11.3 ArcticZymes Technologies DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 ArcticZymes Technologies DNA and RNA Decontamination Solution Product Offerings
7.11.5 ArcticZymes Technologies Recent Development
7.12 Carl Roth
7.12.1 Carl Roth Company Information
7.12.2 Carl Roth Introduction and Business Overview
7.12.3 Carl Roth DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Carl Roth DNA and RNA Decontamination Solution Product Offerings
7.12.5 Carl Roth Recent Development
7.13 Decon Labs
7.13.1 Decon Labs Company Information
7.13.2 Decon Labs Introduction and Business Overview
7.13.3 Decon Labs DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Decon Labs DNA and RNA Decontamination Solution Product Offerings
7.13.5 Decon Labs Recent Development
7.14 GenDEPOT
7.14.1 GenDEPOT Company Information
7.14.2 GenDEPOT Introduction and Business Overview
7.14.3 GenDEPOT DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 GenDEPOT DNA and RNA Decontamination Solution Product Offerings
7.14.5 GenDEPOT Recent Development
7.15 Enzo Life Sciences
7.15.1 Enzo Life Sciences Company Information
7.15.2 Enzo Life Sciences Introduction and Business Overview
7.15.3 Enzo Life Sciences DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Enzo Life Sciences DNA and RNA Decontamination Solution Product Offerings
7.15.5 Enzo Life Sciences Recent Development
7.16 Vazyme
7.16.1 Vazyme Company Information
7.16.2 Vazyme Introduction and Business Overview
7.16.3 Vazyme DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Vazyme DNA and RNA Decontamination Solution Product Offerings
7.16.5 Vazyme Recent Development
7.17 Jiangsu Cowin Biotech
7.17.1 Jiangsu Cowin Biotech Company Information
7.17.2 Jiangsu Cowin Biotech Introduction and Business Overview
7.17.3 Jiangsu Cowin Biotech DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Jiangsu Cowin Biotech DNA and RNA Decontamination Solution Product Offerings
7.17.5 Jiangsu Cowin Biotech Recent Development
7.18 Beijing GenStar
7.18.1 Beijing GenStar Company Information
7.18.2 Beijing GenStar Introduction and Business Overview
7.18.3 Beijing GenStar DNA and RNA Decontamination Solution Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Beijing GenStar DNA and RNA Decontamination Solution Product Offerings
7.18.5 Beijing GenStar Recent Development
8 Industry Chain Analysis
8.1 DNA and RNA Decontamination Solution Industrial Chain
8.2 DNA and RNA Decontamination Solution Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA and RNA Decontamination Solution Sales Model
8.5.2 Sales Channel
8.5.3 DNA and RNA Decontamination Solution Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/01 10:27

150.82 円

163.67 円

197.69 円

ページTOPに戻る